Search

Search Constraints

You searched for: Author/Creator Schell, Michael

Search Results

2. A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer. (30th September 2016)

4. Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. Issue 1 (5th November 2013)

6. A Randomized Phase II Study of Linsitinib (OSI‐906) Versus Topotecan in Patients With Relapsed Small‐Cell Lung Cancer. (30th September 2016)

7. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation. (April 2015)

8. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation. (April 2015)